Similar Items: Immunological Impact of Calprotectin and Interleukin-34 in Immunocompromised Patients with Chronic Cytomegalovirus Infection
- Assessment of Interleukin-31 and Calprotectin in Immunocompromised Patients with Epstein-Barr Virus Infection
- Cytomegalovirus viraemia in immunocompromised children in Cape Town
- Molecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
- Clinical and Immunological Insights into Oral Candidiasis
- Calprotectin Levels in HIV-Infected Patients: Correlations With Disease Progression and Intestinal Inflammation
- Breast Milk-Transmitted Cytomegalovirus Infection in Preterm Infants